Login:
 
Bland P. Weighing up the risks and benefits of smoking cessation therapies. Practitioner 2013; 257 (1766):5

Weighing up the risks and benefits of smoking cessation therapies

05 Dec 2013Pais-up subscribers

A prospective cohort study from the UK has found no evidence that varenicline or bupropion raise the risk of depression, self harm or suicide.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .